You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

history of polycythemia vera

Showing 1 - 25 of 9,024
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution

Recruiting
  • Polycythemia Vera
    • Sohag, Egypt
      Faculty of Medicine
    Aug 12, 2023

    Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

    Not yet recruiting
    • Polycythemia Vera
    • Givinostat Hydrochloride
    • Hydroxy Urea
    • (no location specified)
    Oct 19, 2023

    Polycythemia Vera Trial (Open-label rusfertide)

    Not yet recruiting
    • Polycythemia Vera
    • Open-label rusfertide
    • (no location specified)
    Sep 5, 2023

    Polycythemia Vera Trial (Hydroxyurea)

    Not yet recruiting
    • Polycythemia Vera
    • (no location specified)
    May 2, 2023

    Polycythemia Vera Trial in Italy

    Recruiting
    • Polycythemia Vera
      • Reggio Calabria, Calabria, Italy
      • +21 more
      Nov 10, 2023

      Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

      Recruiting
      • Polycythemia Vera
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      May 19, 2023

      Polycythemia Vera Trial in Hirakata, Izumo, Osaka (PPMX-T003)

      Recruiting
      • Polycythemia Vera
      • Hirakata, Osaka, Japan
      • +2 more
      Nov 14, 2022

      Polycythemia Vera Trial (bomedemstat)

      Not yet recruiting
      • Polycythemia Vera
      • (no location specified)
      Oct 24, 2022

      Real World Evidence of Fedratinib Effectiveness in MF

      Not yet recruiting
      • Primary Myelofibrosis
      • +2 more
      • (no location specified)
      May 22, 2023

      QoL and Symptoms in Polycythemia Vera Receiving Ruxo inRoutine

      Not yet recruiting
      • Polycythemia Vera
      • (no location specified)
      Sep 30, 2022

      Identify and Describe Predictive Factors for Thromboembolic

      Not yet recruiting
      • Polycythemia Vera
      • Hydroxyurea
      • Ruxolitinib
      • (no location specified)
      Nov 2, 2022

      Assess the Safety of Fedratinib in Korean Myelofibrosis

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Polycythemia Vera Trial (SLN124, Placebo)

      Not yet recruiting
      • Polycythemia Vera
      • (no location specified)
      Aug 10, 2022

      Polycythemia Vera Trial (Ropeginterferon alfa-2b-njft (P1101))

      Not yet recruiting
      • Polycythemia Vera
      • Ropeginterferon alfa-2b-njft (P1101)
      • (no location specified)
      Jul 28, 2022

      Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

      Recruiting
      • Myelofibrosis Due to and Following Polycythemia Vera
      • Basking Ridge, New Jersey
      • +6 more
      Jan 26, 2023

      Phlebotomy Dependent Polycythemia Vera Trial in Canada, United Kingdom, United States (IONIS-TMPRSS6-LRx)

      Recruiting
      • Phlebotomy Dependent Polycythemia Vera
      • Orange, California
      • +4 more
      Aug 1, 2022

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

      Active, not recruiting
      • Myelofibrosis
      • Polycythemia Vera
      • Phoenix, Arizona
      • +4 more
      Jun 20, 2022

      Polycythemia Vera Trial (Ruxolitinib)

      Available
      • Polycythemia Vera
      • (no location specified)
      Mar 7, 2022

      Ruxolitinib for Polycythemia Vera in Patients Resistant to or

      Completed
      • Polycythemia Vera (PV)
      • Ruxolitinib
      • East Hanover, New Jersey
        Novartis Investigative Site
      Jun 29, 2022

      Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

      Completed
      • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 27, 2022

      Polycythemia Vera, Essential Thrombocythemia, and

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Next-generation sequencing
      • (no location specified)
      Jun 27, 2022

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera

        Completed
        • Adherence, Patient
        • Adherence, Treatment
          • Cosenza, Calabria, Italy
          • +27 more
          Oct 11, 2023

          Polycythemia Vera Trial in Korea, Republic of, Malaysia (PTG-300)

          Active, not recruiting
          • Polycythemia Vera
          • Incheon, Korea, Republic of
          • +7 more
          Mar 8, 2022